Hepatitis B Vaccination Histories in Persons with HIV Needing Revaccination
Regardless of past vaccine records, antibody titers should be checked in PWH for revaccination needs. The recently approved long-acting (LA) and injectable antiretroviral treatment (ART) lacks protective effect against HBV, unlike tenofovir-based ART. As the LA ART becomes more widely used, we recommend reassessing serologies and offering the recommended CpG-adjuvanted vaccine series with promising response durability to individuals without seroprotection.
Authors
- Ngan Ta Thi Dieu (ORCID: https://orcid.org/0000-0003-4180-6441)
- Stephanie Caruso
- Anchalee Avihingsanon (ORCID: https://orcid.org/0000-0003-3222-9611)
- Karen J. Vigil
- Unoda Chakalisa (ORCID: https://orcid.org/0000-0002-5146-0491)
- Triin Umbleja (ORCID: https://orcid.org/0000-0001-7161-7743)
- Sandra Wagner Cardoso (ORCID: https://orcid.org/0000-0001-5230-0003)
- Kristen Marks (ORCID: https://orcid.org/0000-0003-1896-4978)
- Josphat Kosgei (ORCID: https://orcid.org/0000-0002-0106-524X)
- Minhee Kang
- Kenneth E. Sherman
Institutions
- Hanoi Medical University (VN)
- Cornell University (US)
- Kenya Medical Research Institute (KE)
- Massachusetts General Hospital (US)
- Cancer Research And Biostatistics (US)
- HIV Netherlands Australia Thailand Research Collaboration (TH)
- Frontier Science & Technology Research Foundation, Inc. (US)
- Botswana Harvard AIDS Institute Partnership (BW)
- The University of Texas Health Science Center (US)
- Weill Cornell Medicine (US)
- Fundação Oswaldo Cruz (BR)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1097/qai.0000000000003828
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00